Wednesday, August 26, 2026

Monetary Policy & Markets

2 articles

ECB Signals Further Cuts While Fed Independence Concerns Add Political Risk Premium to Dollar Assets

ECB Signals Further Cuts While Fed Independence Concerns Add Political Risk Premium to Dollar Assets

European Central Bank officials signaled room for additional rate cuts amid favorable inflation data, while emerging market central banks in Indonesia, Chile, and Uruguay maintain data-dependent easing stances. Political uncertainty surrounding Fed Chair Jerome Powell's May 2026 term expiration is creating measurable risk premiums as markets price in potential Trump administration pressure for looser monetary policy.

ViaNews Editorial Team (Markets)
Social Security Insolvency Now Projected for 2032 as Fed Chair Succession Looms in May 2026

Social Security Insolvency Now Projected for 2032 as Fed Chair Succession Looms in May 2026

The One Big Beautiful Bill Act accelerates Social Security's insolvency from 2035 to 2032 through tax cuts reducing federal revenue, while slashing $1.1 trillion from Medicaid. Jerome Powell's Fed Chair term expires May 2026, creating succession uncertainty as the next chair faces pressure to balance presidential loyalty against market credibility during an entitlement crisis.

ViaNews Editorial Team (Markets)
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Leadership Exodus Rattles Investor Confidence Amid Capex Boom
High-profile departures at top AI labs — Brad Lightcap's exit from OpenAI and an unnamed researcher's departure from Alphabet/Google that triggered a share-price drop — are surfacing talent retention as a market risk factor even as hyperscalers pour record capital into AI infrastructure. The reaction shows investors treating key-person risk at frontier AI labs as material to valuation, a new fragility layered onto an otherwise bullish AI-driven capex cycle.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Broadcom Inc.
Both facts report EPS for Broadcom Inc. for the same fiscal period (Q1 2026) observed on the same date (2026-02-01). However, they report conflicting values: 1.5 USD per share vs 2.05 USD per share. This is a 37% difference for the identical metric and time period, not a value change over time.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,978
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,978 facts checked against source5,251 source documents archived
Query this data → isubstrate.com